(PRVL) |
| 0 (0%) 10-10 21:12 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 23.35 |
| Resistance 1: | 23.13 |
| Pivot price: | 23.03 |
| Support 1: | 22.77 |
| Support 2: | 18.94 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 10 Sep 2024
Primary vitreoretinal lymphoma and macular oedema - Nature
Wed, 11 Jan 2023
Lacson ok's promotion of GSO head, assistant prv'l accountant - SunStar Publishing Inc.
Wed, 13 Oct 2021
PRVL Executive clears the air on prize-money queries - Vanuatu Daily Post
Fri, 22 Jan 2021
Lilly Completes Acquisition of Prevail Therapeutics | Eli Lilly and Company - Eli Lilly and Company
Tue, 15 Dec 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics - PR Newswire
Tue, 15 Dec 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics - Eli Lilly and Company
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
